A booster dose of Bivalent Moderna and Pfizer COVID-19 has been approved for ages 65 and older and immunocompromised patients.
Patients aged 65 and older may receive an additional dose of a bivalent vaccine at least four months following their initial bivalent COVID-19 dose.
Immunocompromised patients may receive an additional dose of a bivalent vaccine at least two months following a dose of bivalent COVID-19 vaccine.
If you are eligible, stop in the pharmacy today! No appointments are necessary.
